U.S Physical Therapy Operating Expenses 2012-2026 | USPH

U.S Physical Therapy operating expenses from 2012 to 2026. Operating expenses can be defined as the sum of all operating expenses for the given industry.
Unlock Macrotrends Premium
40 years of data
Faster, ad-free pages
Unlimited data exports
Full-width charts
U.S Physical Therapy Annual Operating Expenses
(Millions of US $)
2025 $694
2024 $608
2023 $553
2022 $496
2021 $424
2020 $371
2019 $415
2018 $394
2017 $359
2016 $307
2015 $284
2014 $259
2013 $225
2012 $211
2011 $200
U.S Physical Therapy Quarterly Operating Expenses
(Millions of US $)
2026-03-31 $186
2025-12-31 $186
2025-09-30 $172
2025-06-30 $172
2025-03-31 $164
2024-12-31 $161
2024-09-30 $155
2024-06-30 $152
2024-03-31 $141
2023-12-31 $156
2023-09-30 $134
2023-06-30 $131
2023-03-31 $132
2022-12-31 $134
2022-09-30 $125
2022-06-30 $121
2022-03-31 $117
2021-12-31 $113
2021-09-30 $109
2021-06-30 $105
2021-03-31 $97
2020-12-31 $99
2020-09-30 $89
2020-06-30 $74
2020-03-31 $109
2019-12-31 $107
2019-09-30 $100
2019-06-30 $106
2019-03-31 $101
2018-12-31 $103
2018-09-30 $98
2018-06-30 $98
2018-03-31 $95
2017-12-31 $95
2017-09-30 $90
2017-06-30 $89
2017-03-31 $85
2016-12-31 $80
2016-09-30 $76
2016-06-30 $75
2016-03-31 $75
2015-12-31 $74
2015-09-30 $72
2015-06-30 $70
2015-03-31 $68
2014-12-31 $69
2014-09-30 $66
2014-06-30 $64
2014-03-31 $60
2013-12-31 $59
2013-09-30 $56
2013-06-30 $56
2013-03-31 $54
2012-12-31 $53
2012-09-30 $53
2012-06-30 $53
2012-03-31 $53
2011-12-31 $52
2011-09-30 $51
2011-06-30 $49
Sector Industry Market Cap Revenue
Medical Medical - Outpatient & Home Care $1.157B $0.781B
U.S. Physical Therapy, Inc. is the largest publicly-traded, pure-play operator of outpatient physical and occupational therapy clinics. The clinics provide pre- and post-operative care for a variety of orthopedic-related disorders and sports-related injuries, rehabilitation of injured workers and preventative care. USPh also manages several physical therapy facilities for third parties, including physician groups. Each of USPh's clinics are directed by a licensed physical therapist that drive patient volume via local physicians, former patients and other referral sources. Marketing representatives are used to further augment sales. Historically, USPh has grown its business through de novo development; approximately two-thirds of USPh clinics were originally start-ups. Strategic acquisitions, which accelerate the Company's growth, are structured like the de novo partnerships, with significant ownership retained by founders.
Stock Name Country Market Cap PE Ratio
Fresenius SE (FSNUY) Germany $29.514B 13.37
Quest Diagnostics (DGX) United States $21.197B 19.44
Elanco Animal Health (ELAN) United States $11.500B 24.35
Encompass Health (EHC) United States $10.662B 19.64
DaVita (DVA) United States $10.023B 13.82
Chemed (CHE) United States $5.639B 19.57
Option Care Health (OPCH) United States $4.553B 18.71
RadNet (RDNT) United States $4.302B 142.13
LifeStance Health (LFST) United States $2.495B 320.00
Addus HomeCare (ADUS) United States $1.719B 16.61
Astrana Health (ASTH) United States $1.536B 31.40
Aveanna Healthcare Holdings (AVAH) United States $1.353B 12.20
Pennant (PNTG) United States $1.072B 31.31
Daxor (DXR) United States $0.048B 0.00
MEDIROM Healthcare Technologies (MRM) Japan $0.032B 0.00
Psychemedics (PMD) United States $0.000B 0.00